Atherosclerosis: Targeting LDL Cholesterol with Statins and PCSK9 Inhibitors for Cardiovascular Disease Management
Received Date: Jun 28, 2023 / Accepted Date: Jul 26, 2023 / Published Date: Jul 27, 2023
Abstract
Atherosclerosis is a complex and chronic inflammatory disease that affects large and medium-sized arteries, leading to severe cardiovascular complications such as ischemic heart disease, strokes, and peripheral vascular disease collectively known as cardiovascular disease (CVD). This review article provides an overview of atherosclerosis, its pathophysiology, and the role of elevated LDL (low-density lipoprotein) cholesterol in its development. Furthermore, it examines the therapeutic options of statins and PCSK9 inhibitors, which have shown significant promise in managing LDL cholesterol levels and reducing major adverse cardiovascular events.
Citation: Stewart C (2023) Atherosclerosis: Targeting LDL Cholesterol with Statins and PCSK9 Inhibitors for Cardiovascular Disease Management. Atheroscler 黑料网 8: 218. Doi: 10.4172/asoa.1000218
Copyright: © 2023 Stewart C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
黑料网 Journals
Article Tools
Article Usage
- Total views: 1273
- [From(publication date): 0-2023 - Mar 10, 2025]
- Breakdown by view type
- HTML page views: 1174
- PDF downloads: 99
